IRIS
SCHWARTZ, PETER
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.058
AS - Asia 15.989
EU - Europa 12.754
SA - Sud America 2.044
AF - Africa 451
Continente sconosciuto - Info sul continente non disponibili 356
OC - Oceania 62
Totale 56.714
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.117
CN - Cina 8.609
SG - Singapore 3.374
IE - Irlanda 2.611
UA - Ucraina 2.039
DE - Germania 1.828
HK - Hong Kong 1.554
BR - Brasile 1.509
IT - Italia 1.200
FI - Finlandia 1.190
RU - Federazione Russa 1.170
VN - Vietnam 1.085
SE - Svezia 904
FR - Francia 765
GB - Regno Unito 632
CA - Canada 404
IN - India 271
BD - Bangladesh 222
ZA - Sudafrica 178
AR - Argentina 174
IQ - Iraq 149
MX - Messico 112
JP - Giappone 100
EC - Ecuador 82
CO - Colombia 80
NL - Olanda 80
VE - Venezuela 76
PK - Pakistan 72
TR - Turchia 71
MA - Marocco 62
CR - Costa Rica 61
ID - Indonesia 58
ES - Italia 57
TT - Trinidad e Tobago 55
CW - ???statistics.table.value.countryCode.CW??? 53
AT - Austria 51
IL - Israele 50
BE - Belgio 47
PH - Filippine 47
GT - Guatemala 46
NI - Nicaragua 46
PL - Polonia 46
SV - El Salvador 43
HN - Honduras 42
CL - Cile 41
UZ - Uzbekistan 40
GP - Guadalupe 36
SA - Arabia Saudita 36
KE - Kenya 35
MY - Malesia 34
PY - Paraguay 33
TN - Tunisia 33
AU - Australia 32
MU - Mauritius 32
PR - Porto Rico 32
JM - Giamaica 31
JO - Giordania 29
EG - Egitto 27
NZ - Nuova Zelanda 27
AE - Emirati Arabi Uniti 24
IR - Iran 22
AZ - Azerbaigian 21
PE - Perù 20
NP - Nepal 19
EU - Europa 17
DZ - Algeria 16
BO - Bolivia 15
ET - Etiopia 15
SC - Seychelles 14
CZ - Repubblica Ceca 13
OM - Oman 13
UY - Uruguay 13
AL - Albania 12
KZ - Kazakistan 11
LT - Lituania 10
LV - Lettonia 10
PT - Portogallo 9
RO - Romania 9
SN - Senegal 9
TH - Thailandia 9
BG - Bulgaria 8
CH - Svizzera 8
EE - Estonia 8
KR - Corea 8
LB - Libano 8
PS - Palestinian Territory 8
RS - Serbia 8
BB - Barbados 7
DK - Danimarca 7
HU - Ungheria 7
PA - Panama 7
DO - Repubblica Dominicana 6
KG - Kirghizistan 6
AM - Armenia 5
BS - Bahamas 5
GE - Georgia 5
GR - Grecia 5
KW - Kuwait 5
QA - Qatar 5
BA - Bosnia-Erzegovina 3
Totale 56.350
Salva come PNG Salva come JPEG
Città #
Chandler 2.645
Dublin 2.605
Jacksonville 2.601
San Jose 2.196
Nanjing 2.101
Ashburn 1.805
Singapore 1.576
Dallas 1.547
Hong Kong 1.517
Council Bluffs 1.514
Beijing 984
Boardman 905
Nanchang 854
Princeton 642
Lawrence 605
Shenyang 600
Changsha 577
Hebei 571
Wilmington 564
Lauterbourg 540
Jiaxing 511
Munich 482
Los Angeles 439
Helsinki 425
Medford 408
Ho Chi Minh City 379
Tianjin 332
Hangzhou 326
Hanoi 263
Moscow 232
Buffalo 226
Redondo Beach 224
New York 212
Santa Clara 197
Ann Arbor 195
Milan 187
Woodbridge 149
São Paulo 144
Shanghai 140
Johannesburg 138
Verona 123
Norwalk 115
Toronto 97
Tokyo 94
Houston 91
Brooklyn 87
Orem 85
Chicago 76
Frankfurt am Main 72
Nuremberg 70
Rome 70
Seattle 69
Fairfield 65
Atlanta 64
Baghdad 64
Washington 61
Des Moines 60
Kunming 59
San Francisco 57
Pavia 53
Zhengzhou 53
Guangzhou 52
Mcallen 52
Willemstad 51
Chennai 50
Denver 49
Montreal 49
Phoenix 47
Managua 46
Da Nang 44
Falkenstein 44
Jinan 44
San José 44
Falls Church 42
Columbus 40
London 40
North Bergen 39
Haiphong 38
Brasília 37
Charlotte 37
Montréal 37
Warsaw 37
Brussels 36
Ningbo 36
Tashkent 36
Boston 35
Mexico City 35
Rio de Janeiro 35
Belo Horizonte 34
Guatemala City 33
Nairobi 33
Philadelphia 32
Stockholm 32
The Dalles 32
Turku 32
Guayaquil 30
Manchester 30
San Salvador 30
Caracas 29
Curitiba 29
Totale 35.651
Salva come PNG Salva come JPEG
Nome #
[A new experimental model for the study of arrhythmias dependent on the interaction between myocardial ischemia and sympathetic hyperactivity. I. Effects of phosphocreatinine]. 311
Identificazione di microRNA circolanti specificatamente sovra espressi in corso di infarto miocardico acuto. 276
[Legal implications of medical guidelines. A Task Force of the European Society of Cardiology]. 275
[Changes of a reflex nature in the cardiac sympathetic activity induced with increases of arterial pressure in spinal animals]. 275
[Idiopathic syndrome of the long QT interval--the need for a prospective study]. 266
Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions. 265
Calcio antagonisti e aritmie da riperfusione miocardica 217
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. 202
Pathophysiological rationale for cardiac vagal denervation in the treatment of atrial fibrillation 187
Long QT and short QT syndromes. 186
FGF12 is a candidate Brugada syndrome locus. 164
Genotype-Phenotype correlation in the Long QT Syndrome. Gene-specific triggers for life-threatening arrhythmias 163
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. 161
[Activity of preganglionic sympathetic single fibers during experimental coronary occlusion]. 159
[Infant mortality and sudden crib death in Lombardy]. 159
[Neonatal electrocardiography and the sudden infant death syndrome (SIDS)]. 156
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 155
[Activity of afferent cardiac vagal fibers during experimental myocardial ischemia]. 154
Aspetti elettrofisiologici della modulazione dei canali del potassio ATP-dipendenti 154
[Idiopathic ventricular fibrillation: from a collection of clinical cases to a prospective evaluation. The U-CARE Steering Committee. Unexplained Cardiac Arrest Registry of Europe]. 149
Spectrum and prevalence of mutations involving BrS1-12 susceptibility genes in a cohort of unrelated patients referred for Brugada Syndrome genetic testing: implications for genetic testing. 148
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis. 148
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. 147
[Electrophysiologic features of the modulation of ATP-dependent potassium channels]. 144
Long QT syndrome-associated mutations in intrauterine fetal death. 141
Effect of Considering the Relatives' Quality of Life in Cost-Utility Studies 141
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1. 141
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 141
The genetics underlying acquired long QT syndrome: impact for genetic screening. 139
25th anniversary of the International Long-QT Syndrome Registry: an ongoing quest to uncover the secrets of long-QT syndrome. 138
Risk stratification in the Long-QT Syndrome 137
[Long QT syndrome and Brugada syndrome: 2 aspects of the same disease?]. 137
[Study of preganglionic sympathetic single fibers in relation to various physiologic and pathologic stimuli]. 137
Electrocardiographic and genetic screening for long QT syndrome: results from a prospective study on 44,596 neonates. 136
Antifibrillatory efficacy of ersentilide, a novel beta-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction. 135
Alpha 1-adrenergic blockade and sudden cardiac death. 134
Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. 134
Linee Guida. Task Force sulla Morte Cardiaca Improvvisa, Società Europea di Cardiologia. Riassunto delle raccomandazioni 133
Novel human pathological mutations. Gene symbol: SCN5A. Disease: Brugada Syndrome. 132
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 132
[Cardio-cardiac sympathico-vagal reflex]. 131
A Recessive Variant of the Romano-Ward Long QT Syndrome 129
[Sympathetic reflex induced by experimental coronary occlusion]. 128
Cost-effectiveness of Neonatal ECG as a Screening for Long QT-syndrome: A Decision Analysis Approach. 127
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. 127
QT prolongation and sudden infant death syndrome - from theory to evidence. 126
[Baroceptive reflex sensibility in non-anesthetized animals. Evaluation and comparison of 2 methods applicable to humans]. 126
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 126
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 125
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 125
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome. 124
Age and sex-related differences in the clinical manifestations of congenital long QT syndrome: findings from the International Prospective LQTS Registry 124
All LQT3 patients need an ICD. True or false? 123
Inherited cardiac arrhythmia syndrome. Role of potassium channels 123
Cardiac potassium channel dysfunction in sudden infant death syndrome. 123
Adrenergic Arrhythmogenesis and The Long QT syndrome 123
[Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method]. 123
Arrhythmogenic disorders of genetic origin. Long QT Syndrome: from genetics to management. 122
Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome. 121
A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5. 121
Unexplained cardiac arrest. The need for a prospective registry. 121
Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1? 121
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 121
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (ranolazine in atrial fibrillation following an electrical cardioversion) study 121
QT prolongation, sudden death, and sympathetic imbalance: the pendulum swings. 120
An experimental approach to the choice of antiarrhythmic therapy. 120
[Sudden death after myocardial infarction. Prediction based on the baroreceptor reflex]. 120
[Neural mechanisms of sudden death]. 120
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 120
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome. 119
Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. 119
Cardiac sodium channel dysfunction in sudden infant death syndrome. 119
A common polymorphism associated with antibiotic-induced cardiac arrhythmia 119
Mortalità infantile e morte improvvisa in culla in Lombardia 119
Farmaci antipsicotici, QT lungo, morte improvvisa e rischio cardiovascolare. Il cardiologo incontra lo psichiatra 118
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation 118
ALIVE Investigators: The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial. 117
Update of the guidelines on sudden cardiac death of the European Society of Cardiology 117
The LQT2 KCNH2-Q376Q splicing muation: functional characterization, molecular correction and therapeutic implication. 117
QT lungo, sindrome del 117
New mutations in the KVLQT1 potassium channel that cause long QT Syndrome. 117
Sertraline treatment of major depression in patients with acute MI or unstable angina. 117
Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. 117
Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE). 117
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 117
Autonomic Modulation for the Management of Patients with Chronic Heart Failure 116
Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism 115
K+ channel blockade in the prevention of ventricular fibrillation in dogs with acute ischemia and enhanced sympathetic activity. 115
Rapid heart rate increase at onset of exercise predicts adverse cardiac events in patients with coronary artery disease 115
Prevalence of the congenital long-QT syndrome. 115
Autonomic nervous system, myocardial ischemia, and malignant ventricular arrhythmias: Experimental findings 115
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 115
Legal implications of medical guidelines. A task Force of the European Society of Cardiology 114
Individual autonomic profile contributes to the risk for life-threatening arrhythmias among KCNQ1-A341V mutation carriers 114
The long QT syndrome. Prospective longitudinal study of 328 families. 114
Diagnostic criteria for the long QT syndrome. An update. 114
KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. 114
Baroreceptor reflexes and sudden cardiac death: experimental findings and background. 114
[Long-QT caused by drugs and torsade de pointes: a genetic basis?]. 113
A Refined Multiscale Self-Entropy Approach for the Assessment of Cardiac Control Complexity: Application to Long QT Syndrome Type 1 Patients 113
Totale 13.990
Salva come PNG Salva come JPEG
Categoria #
all - tutte 241.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 241.419
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.260 0 0 0 0 34 176 30 129 173 67 390 1.261
2022/20237.639 921 455 58 608 836 888 6 456 3.103 34 170 104
2023/20242.416 259 528 108 197 280 647 52 128 7 67 69 74
2024/20257.226 120 683 194 251 110 284 617 756 1.604 222 627 1.758
2025/202615.671 1.114 1.197 2.185 1.436 1.632 756 3.152 637 1.278 1.197 707 380
2026/20275.783 333 1.044 1.225 2.070 1.111 0 0 0 0 0 0 0
Totale 56.714